Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-23
DOI
10.3389/fphar.2021.648921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of intramuscular and intravenous pharmacokinetics of ginsenosides in humans after dosing XueShuanTong, a lyophilized extract of Panax notoginseng roots
- (2020) Hai-Yan Zhang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Theo Vos et al. LANCET
- Stroke in China: advances and challenges in epidemiology, prevention, and management
- (2019) Simiao Wu et al. LANCET NEUROLOGY
- Intravenous formulation of Panax notoginseng root extract: human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions
- (2019) Salisa Pintusophon et al. ACTA PHARMACOLOGICA SINICA
- Neuroinflammation: friend and foe for ischemic stroke
- (2019) Richard L. Jayaraj et al. Journal of Neuroinflammation
- Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Maigeng Zhou et al. LANCET
- Global brain inflammation in stroke
- (2019) Kaibin Shi et al. LANCET NEUROLOGY
- National Institutes of Health Stroke Scale
- (2019) Vicky Chalos et al. STROKE
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2019) William J. Powers et al. STROKE
- Panax notoginseng Saponins Protect Cerebral Microvascular Endothelial Cells against Oxygen-Glucose Deprivation/Reperfusion-Induced Barrier Dysfunction via Activation of PI3K/Akt/Nrf2 Antioxidant Signaling Pathway
- (2018) Shaonan Hu et al. MOLECULES
- Panax notoginseng Saponins Attenuate Oxygen–Glucose Deprivation/Reoxygenation-Induced Injury in Human SH-SY5Y Cells by Regulating the Expression of Inflammatory Factors through miR-155
- (2018) Lanqing Meng et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Evaluating the protective mechanism of panax notoginseng saponins against oxidative stress damage by quantifying the biomechanical properties of single cell
- (2018) Miaomiao Zhang et al. ANALYTICA CHIMICA ACTA
- Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2017) Shadi Yaghi et al. STROKE
- Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation
- (2016) Ángel Chamorro et al. LANCET NEUROLOGY
- Panax notoginseng saponins administration modulates pro- /anti-inflammatory factor expression and improves neurologic outcome following permanent MCAO in rats
- (2016) Xiaowei Shi et al. METABOLIC BRAIN DISEASE
- Early Blood Brain Barrier Changes in Acute Ischemic Stroke: A Sequential MRI Study
- (2015) Marc Giraud et al. JOURNAL OF NEUROIMAGING
- Protective effect of ginsenoside Rb1 on integrity of blood–brain barrier following cerebral ischemia
- (2015) Wei Chen et al. EXPERIMENTAL BRAIN RESEARCH
- Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke
- (2014) Jens Neumann et al. ACTA NEUROPATHOLOGICA
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
- (2013) An-Wen Chan et al. ANNALS OF INTERNAL MEDICINE
- Panax notoginseng saponins inhibit ischemia-induced apoptosis by activating PI3K/Akt pathway in cardiomyocytes
- (2011) Shaoxian Chen et al. JOURNAL OF ETHNOPHARMACOLOGY
- Comparative study on saponin fractions from Panax notoginseng inhibiting inflammation-induced endothelial adhesion molecule expression and monocyte adhesion
- (2011) Nan Wang et al. Chinese Medicine
- Inflammatory and Neuroimmunomodulatory Changes in Acute Cerebral Ischemia
- (2009) David Brea et al. CEREBROVASCULAR DISEASES
- Panax notoginseng Reduces Atherosclerotic Lesions in ApoE-Deficient Mice and Inhibits TNF-α-Induced Endothelial Adhesion Molecule Expression and Monocyte Adhesion
- (2009) Jian-Bo Wan et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now